Journal of Hepatology
Volume 41, Issue 1 , Pages 49-54 , July 2004

Intestinal glutaminase activity is increased in liver cirrhosis and correlates with minimal hepatic encephalopathy

  • Manuel Romero-Gómez

      Affiliations

    • Hepatology Unit, Hospital Universitario de Valme, Ctra Cádiz s/n, 41014 Sevilla, Spain
    • Corresponding Author InformationCorresponding author. Fax: +34-9546-81006
    • ,
  • Rosa Ramos-Guerrero

      Affiliations

    • Department of Pharmacy, Hospital Universitario Virgen del Rocio, Sevilla, Spain
    • ,
  • Lourdes Grande

      Affiliations

    • Hepatology Unit, Hospital Universitario de Valme, Ctra Cádiz s/n, 41014 Sevilla, Spain
    • ,
  • Laura Collantes de Terán

      Affiliations

    • Department of Biochemistry, Bromatology and Toxicology, Faculty of Pharmacy, Universidad de Sevilla, Sevilla, Spain
    • ,
  • Raquel Corpas

      Affiliations

    • Hepatology Unit, Hospital Universitario de Valme, Ctra Cádiz s/n, 41014 Sevilla, Spain
    • ,
  • Inés Camacho

      Affiliations

    • Biochemistry Unit, Hospital Universitario de Valme, Sevilla, Spain
    • ,
  • Juan D. Bautista

      Affiliations

    • Department of Biochemistry, Bromatology and Toxicology, Faculty of Pharmacy, Universidad de Sevilla, Sevilla, Spain

Received 1 November 2003 ,Revised 8 February 2004 ,Accepted 26 March 2004.

References 

  1. Butterworth RF. Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metab Brain Dis. 2002;17:221–227
  2. Sherlock S. Chronic portal-systemic encephalopathy: update 1987. Gut. 1987;28:1043–1048
  3. Oppong KN, Al-Mardini H, Thick M, Record CO. Oral glutamine challenge in cirrhotics pre- and post-liver transplantation: a psychometric and analysed EEG study. Hepatology. 1997;26:870–876
  4. Romero-Gómez M, Grande L, Camacho I, Benitez S, Irles JA, Castro M. Altered response to oral glutamine challenge as prognostic factor for overt episodes in patients with minimal hepatic encephalopathy. J Hepatol. 2002;37:871–877
  5. Nance FC, Kline DG. Eck's fistula encephalopathy in germ-free dogs. Ann Surg. 1971;174:856–861
  6. Warren KS, Newton WL. Portal and peripheral blood ammonia concentrations in germ-free and conventional guinea pigs. Am J Physiol. 1959;197:717–720
  7. Weber FJL, Veach GL. The importance of the small intestine in gut ammonium production in the fasting dog. Gastroenterology. 1979;77:235–240
  8. Olde Damink SW, Jalan R, Redhead DN, Hayes PC, Deutz NE, Soeters PB. Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS. Hepatology. 2002;36:1163–1171
  9. Amodio P, Del Piccolo F, Marchetti P, Angeli P, Iemmolo R, Caregaro L, et al.  Clinical features and survival of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric test. Hepatology. 1999;29:1662–1667
  10. Haser WG, Shapiro RA, Curthoys NP. Comparison of the phosphate-dependent glutaminase obtained from rat brain and kidney. Biochem J. 1985;229:399–408
  11. Quesada AR, Sanchez-Jimenez F, Perez-Rodriguez J, Marquez J, Medina MA, Nunez de Castro I. Purification of phosphate-dependent glutaminase from isolated mitochondria of Ehrlich ascites-tumour cells. Biochem J. 1988;255:1031–1035
  12. Lund P. l-Glutamine and l-Glutamate: UV-method with glutaminase and glutamate dehydrogenase. In:  Bermeyer HU editors. Methods of enzymatic analysis. vol. 8:1988;p. 357–363 Weinheim
  13. Kvamme E, Svenneby G, Tveter KJ, Torgner IA. Phosphate-activated glutaminase in human kidney. Contrib Nephrol. 1985;47:145–149
  14. Hawkins RA, Jessy J, Mans AM, Chedid A, DeJoseph MR. Neomycin reduces the intestinal production of ammonia from glutamine. In:  Felipo V,  Grisolı́a S editor. Hepatic encephalopathy, hyperammonemia and ammonia toxicity. New York: Plenum; 1994;p. 125–134
  15. Romero Gomez M, Boza F, Garcia Valdecasas MS, Garcı́a E, Aguilar Reina J. Sub-clinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol. 2001;96:2718–2723
  16. Masini A, Efrati C, Merli M, Attili AF, Amodio P, Ceccanti M, et al.  Effect of lactitol on blood ammonia response to oral glutamine challenge in cirrhotic patients: evidence for an effect of nonabsorbable disaccharides on small intestine ammonia generation. Am J Gastroenterol. 1999;94:3323–3327
  17. Das A, Dhiman RK, Saraswat VA, Verma M, Naik SR. Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. J Gastroenterol Hepatol. 2001;16:531–535
  18. Hartmann IJC, Groeneweg M, Quero JC, Beijeman SJ, Man RA, Hop WCJ, et al.  The prognostic significance of sub-clinical hepatic encephalopathy. Am J Gastroenterol. 2000;95:2029–2034
  19. Gitlin N, Lewis DC, Hinkley L. The diagnosis and prevalence of sub-clinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis. J Hepatol. 1986;3:75–82
  20. Balata S, Damink SW, Ferguson K, Marshall I, Hayes PC, Deutz NE, et al.  Induced hyperammonemia alters neuropsychology, brain MR spectroscopy and magnetization transfer in cirrhosis. Hepatology. 2003;37:931–939
  21. Spahr L, Vingerhoets F, Lazeyras F, Delavelle J, DuPasquier R, Giostra E, et al.  Magnetic resonance imaging and proton spectroscopic alterations correlate with Parkinsonian signs in patients with cirrhosis. Gastroenterology. 2000;119:774–781
  22. McCauley R, Kong SE, Heel K, Hall JC. The role of glutaminase in the small intestine. Int J Biochem Cell Biol. 1999;31:405–413
  23. Kovacecevic Z, McGivan JD. Mitochondrial metabolism of glutamine and glutamate and its phycological significance. Physiol Rev. 1983;63:547–605
  24. James LA, Lunn PG, Middleton S, Elia M. Distribution of glutaminase and glutamine synthetase activities in the human gastrointestinal tract. Clin Sci. 1998;94:313–319
  25. James LA, Lunn PG, Elia M. Glutamine metabolism in the gastrointestinal tract of the rat assessed by the relative activity of gutaminase (EC 3.5.1.2) and glutamine synthetase (EC 6.3.1.2). Br J Nutr. 1988;79:365–372
  26. Pinkus LM, Windmueller HG. Phosphaste-dependent glutaminase of small intestine: localization and role in intestinal glutamine metabolism. Arch Biochem Biophys. 1977;182:506–517
  27. Watford M, Chellaraj V, Ismat A, Brown P, Raman P. Hepatic glutamine metabolism. Nutrition. 2002;18:301–303
  28. Elia M. Glutamine metabolism in adipose tissue in vivo. Clin Nutr. 1993;12:50–53
  29. Corvera S, Garcia-Sainz JA. Hormonal stimulation of mitochondrial glutaminase. Effects of vasopressin, angiotensin II, adrenaline and glucagons. Biochem J. 1983;210:957–960
  30. Marco J, Diego J, Villaneuva ML. Elevated plasma glucagon levels in cirrhosis of the liver. N Engl J Med. 1973;289:1107–1111
  31. Taylor L, Liu X, Newsome W, Shapiro RA, Srinivasan M, Curthoys NP. Isolation and characterization of the promoter region of the rat kidney-type glutaminase gene. Biochim Biophys Acta. 2001;1518:132–136

PII: S0168-8278(04)00157-6

doi: 10.1016/j.jhep.2004.03.021

Journal of Hepatology
Volume 41, Issue 1 , Pages 49-54 , July 2004

Article Tools

* Image Usage & Resolution